H.R. 10628 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Sep 28, 2026
2nd SessionH. R. 10628
A BILL
Biosimilars Access and Affordability Act
Sponsor: Rep. Nicholas A. Langworthy (R-NY-23) · Introduced Sep 28, 2026 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Sep 28, 2026: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”